Patents by Inventor David Karpf

David Karpf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating polycystic ovary syndrome
    Patent number: 11858932
    Abstract: Polycystic ovary syndrome (PCOS) is characterized by elevated levels of androgens, cysts in the ovaries, and irregular periods. Women with PCOS present with additional symptoms, including hirsutism, alopecia, acne, infertility, weight gain, fatigue, depression and mood changes. The present disclosure provides new compounds, salts, compositions and uses thereof in the treatment of PCOS due to elevated adrenal androgens. Further, the present disclosure provides methods for treating PCOS due to elevated adrenal androgens.
    Type: Grant
    Filed: June 13, 2023
    Date of Patent: January 2, 2024
    Assignee: Spruce Biosciences, Inc.
    Inventors: Christopher Barnes, David Karpf, Mustafa Noor
  • METHODS AND COMPOSITIONS FOR TREATING POLYCYSTIC OVARY SYNDROME
    Publication number: 20230322775
    Abstract: Polycystic ovary syndrome (PCOS) is characterized by elevated levels of androgens, cysts in the ovaries, and irregular periods. Women with PCOS present with additional symptoms, including hirsutism, alopecia, acne, infertility, weight gain, fatigue, depression and mood changes. The present disclosure provides new compounds, salts, compositions and uses thereof in the treatment of PCOS due to elevated adrenal androgens. Further, the present disclosure provides methods for treating PCOS due to elevated adrenal androgens.
    Type: Application
    Filed: June 13, 2023
    Publication date: October 12, 2023
    Inventors: Christopher BARNES, David KARPF, Mustafa NOOR
  • METHODS AND COMPOSITIONS FOR TREATING POLYCYSTIC OVARY SYNDROME
    Publication number: 20230295161
    Abstract: Polycystic ovary syndrome (PCOS) is characterized by elevated levels of androgens, cysts in the ovaries, and irregular periods. Women with PCOS present with additional symptoms, including hirsutism, alopecia, acne, infertility, weight gain, fatigue, depression and mood changes. The present disclosure provides new compounds, salts, compositions and uses thereof in the treatment of PCOS due to elevated adrenal androgens. Further, the present disclosure provides methods for treating PCOS due to elevated adrenal androgens.
    Type: Application
    Filed: February 9, 2023
    Publication date: September 21, 2023
    Inventors: Christopher BARNES, David KARPF, Mustafa NOOR
  • Treatment of NAFLD and NASH
    Patent number: 11179359
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: November 23, 2021
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Methods of reducing small, dense LDL particles
    Patent number: 11007162
    Abstract: The present invention provides methods for increasing LDL particle size.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: May 18, 2021
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: David Karpf, Ronald M. Krauss, Yun-Jung Choi, Xueyan Wang, Francine M. Gregoire
  • Treatment of NAFLD and NASH
    Publication number: 20210038546
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: June 19, 2020
    Publication date: February 11, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Patent number: 10722483
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: July 28, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20200009092
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: May 23, 2019
    Publication date: January 9, 2020
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • METHODS OF REDUCING SMALL, DENSE LDL PARTICLES
    Publication number: 20190298672
    Abstract: The present invention provides methods for increasing LDL particle size.
    Type: Application
    Filed: October 31, 2018
    Publication date: October 3, 2019
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: David Karpf, Ronald M. Krauss, Yun-Jung Choi, Xueyan Wang, Francine M. Gregoire
  • Treatment of NAFLD and NASH
    Patent number: 10342770
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: July 9, 2019
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20190142776
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: December 17, 2018
    Publication date: May 16, 2019
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment for NAFLD and NASH
    Patent number: 10188620
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: January 29, 2019
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20180228752
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: April 3, 2018
    Publication date: August 16, 2018
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Patent number: 9962346
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: May 8, 2018
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20180008566
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: March 2, 2017
    Publication date: January 11, 2018
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Patent number: 9616039
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: April 11, 2017
    Assignee: CYMABAY THERAPEUTICS, INC.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20160324812
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: June 2, 2016
    Publication date: November 10, 2016
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • METHODS OF REDUCING SMALL, DENSE LDL PARTICLES
    Publication number: 20160324811
    Abstract: The present invention provides methods for increasing LDL particle size.
    Type: Application
    Filed: January 13, 2016
    Publication date: November 10, 2016
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: David Karpf, Ronald M. Krauss, Yun-Jung Choi, Xueyan Wang, Francine M. Gregoire
  • Treatment of NAFLD and NASH
    Patent number: 9381181
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: July 5, 2016
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20150290154
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 15, 2015
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter